Gainesville, FL, United States of America

Michael J Clare-Salzler

USPTO Granted Patents = 8 

Average Co-Inventor Count = 1.6

ph-index = 2

Forward Citations = 70(Granted Patents)


Location History:

  • Los Angeles, CA (US) (1995)
  • Gainesville, FL (US) (1997 - 2021)

Company Filing History:


Years Active: 1995-2021

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Michael J Clare-Salzler: Innovator in Immunotherapy

Introduction

Michael J Clare-Salzler is a prominent inventor based in Gainesville, FL (US). He has made significant contributions to the field of immunotherapy, holding a total of 8 patents. His work focuses on developing innovative solutions for immune diseases and autoimmune disorders.

Latest Patents

One of his latest patents is titled "Antigen-specific, tolerance-inducing microparticles and uses thereof." This invention provides antigen-specific, tolerance-inducing microparticles designed for the targeted delivery of therapeutic agents to immune cells. The invention allows for the sustained release of therapeutic agents over a prolonged period, enhancing treatment efficacy. It also outlines therapeutic applications for the prevention and treatment of immune diseases and autoimmune disorders, with a specific embodiment aimed at treating type 1 diabetes.

Career Highlights

Michael has worked with notable organizations, including the University of Florida Research Foundation and the University of California. His career reflects a commitment to advancing medical science through innovative research and development.

Collaborations

Throughout his career, Michael has collaborated with esteemed colleagues such as Allan J Tobin and Mark G Erlander. These partnerships have contributed to the success of his research and the development of his patents.

Conclusion

Michael J Clare-Salzler's work in immunotherapy exemplifies the impact of innovation in addressing complex medical challenges. His contributions continue to pave the way for advancements in the treatment of autoimmune disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…